2024-12-01 2025-11-30 false No description of principal activity Capium Accounts Production 1.1 15265305 2024-12-01 2025-11-30 15265305 bus:FullAccounts 2024-12-01 2025-11-30 15265305 bus:Micro-entities 2024-12-01 2025-11-30 15265305 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 15265305 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 15265305 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 15265305 2024-12-01 2025-11-30 15265305 2025-11-30 15265305 bus:RegisteredOffice 2024-12-01 2025-11-30 15265305 core:WithinOneYear 2025-11-30 15265305 core:AfterOneYear 2025-11-30 15265305 1 2024-12-01 2025-11-30 15265305 bus:Director1 2024-12-01 2025-11-30 15265305 bus:Director1 2025-11-30 15265305 bus:Director1 2023-12-01 2024-11-30 15265305 2023-12-01 15265305 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 15265305 2023-12-01 2024-11-30 15265305 2024-11-30 15265305 core:WithinOneYear 2024-11-30 15265305 core:AfterOneYear 2024-11-30 15265305 bus:EntityAccountantsOrAuditors 2023-12-01 2024-11-30 15265305 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 15265305 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 15265305 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 15265305 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15265305 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15265305 core:Non-currentFinancialInstruments 2025-11-30 15265305 core:Non-currentFinancialInstruments 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15265305
England and Wales
TERRAPY LTD
Unaudited Financial Statements
Period of accounts Start date: 01 December 2024 End date: 30 November 2025

TERRAPY LTD Contents Page For the year ended 30 November 2025
Company information | 1
Statement of financial position | 2

TERRAPY LTD Company Information For the year ended 30 November 2025
Director | Andrea Marosvolgyi
Registered Number | 15265305
Registered Office | 8f Gilbert Place London WC1A 2JD
Accountants | NO1 ACCOUNTANTS LTD Office 1 One Coldbath Square London EC1R 5HL
1

TERRAPY LTD Statement of Financial Position As at 30 November 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Current assets |  | (4) |  |  | 2,099 |
Creditors: amount falling due within one year |  | (4,379) |  |  | (5,093) |
Net current assets |  |  | (4,383) |  |  | (2,994)
Total assets less current liabilities |  |  | (4,383) |  |  | (2,994)
Net assets |  |  | (4,383) |  |  | (2,994)
Capital and reserves |  |  | (4,383) |  |  | (2,994)
NOTES TO THE ACCOUNTS General Information TERRAPY LTD is a private company, limited by shares, registered in England and Wales, registration number 15265305, registration address 8f Gilbert Place, London, WC1A 2JD. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 02 April 2026 and were signed by:
-------------------------------- Andrea Marosvolgyi Director
2